Berthel Fisher & Co Financial Services’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Other funds holding TVTX
Berthel Fisher & Co Financial Services's TVTX Position: Q3 2026 in Review
Berthel Fisher & Co Financial Services sold out of Travere Therapeutics (TVTX) in Q3 2026, closing a stake of 67 shares — an estimated $3.81K sold.
Berthel Fisher & Co Financial Services first reported a position in TVTX in Q4 2025 and held it in 3 quarters. The position peaked at $3.81K in Q2 2026. 345 funds tracked by Wall St. Rank hold TVTX as of Q3 2026.
- Berthel Fisher & Co Financial Services reported no remaining Travere Therapeutics position as of Q3 2026 after selling out during the quarter.
- Berthel Fisher & Co Financial Services sold 67 Travere Therapeutics shares in Q3 2026, an estimated $3.81K.
- Berthel Fisher & Co Financial Services first reported a position in Travere Therapeutics in Q4 2025 and held it in 3 quarters.
- Berthel Fisher & Co Financial Services's Travere Therapeutics position peaked at $3.81K in Q2 2026.
- 345 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2026.
Based on Berthel Fisher & Co Financial Services's 13F filing for Q3 2026, filed 13 Nov 2026.